The benefit of treating isolated systolic hypertension

Current Hypertension Reports

Volumn 3, Issue 4, 2001, Pages 333-339

  Wang, Ji Guang ^a   Staessen, Jan A ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; REVIEW; RISK FACTOR; SYSTOLE;

AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; RISK FACTORS; SYSTOLE;

EID: 0035430764     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0096-5     Document Type: Article

References (35)

1. Staessen J, Amery A, Fagard R: Editorial review. Isolated systolic hypertension in the elderly. J Hypertens 1990, 8:393-405.
2. Staessen J, O'Brien E, Atkins N, et al: The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometry. Am J Epidemiol 1992, 136:450-459.
3. Franklin SS, Gustin WIV, Wong ND, et al: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96:308-315.
4. Staessen JA, Gasowski J, Wang J.G., et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000, 355:865-872.
5. MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
6. Gardner MJ, Heady JA: Some effects of within-person variability in epidemiological studies. J Chron Dis 1973, 26:781-795.
7. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
8. Staessen JA, Fagard R, Thijs L., et al.: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350:757-764.
9. Liu L, Wang JG, Gong L, et al: Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens 1998, 16:1823-1829.
10. Amery A, Birkenhäger W, Brixko P., et al.: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985, 1:1349-1354.
11. Coope J, Warrender TS: Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986, 293:1145-1151.
12. Dahlöf B., Lindholm LH, Hansson L, et al: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991, 338:1281-1285.
13. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992, 304:405-412.
14. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J 1985, 291:97-104.
15. Blacher J, Staessen JA, Girerd X, et al: Pulse pressure - not mean pressure - determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000, 160:1085-1089.
16. Millar JA, Lever AF, Burke V: Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999, 17:1065-1072.
17. Curb JD, Pressel SL, Cutler J.A., et al.: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996, 276:1886-1892.
18. Staessen JA, Fagard R, Thijs L., et al.: Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly. Arch Intern Med 1998, 158:1681-1691.
19. Tuomilehto J, Rastenyte D, Birkenhäger WH, et al.: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999, 340:677-684.
20. Staessen JA, Thijs L, Fagard R.H., et al.: Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension. Hypertension 1998, 32:410-416.
21. Forette F, Amery A, Staessen J., et al.: Is prevention of vascular dementia possible ? The Syst-Eur Vascular Dementia Project. Aging Clin Exp Res 1991, 3:373-382.
22. Seux ML, Thijs L, Forette F., et al.: Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens 1998, 16:963-969.
23. Forette F, Seux ML, Staessen J.A., et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347-1351.
24. Seux ML, Forette F: Effects of hypertension and its treatment on mental function. Curr Hypertens Rep 1999, 3:232-237.
25. Voyaki SM, Staessen JA, Thijs L, et al: Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. J Hypertens 2001, 19:511-519.
26. Collaborative Group Coordinating Center: Systolic hypertension in the elderly: Chinese trial (Syst-China) - interim report. Chin J Cardiol 1992, 20:270-275.
27. Wang JG, Liu G, Wang X., et al.: Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial. J Hum Hypertens 1996, 10: 735-742.
28. Wang JG, Staessen JA, Gong L, et al: Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 2000, 160:211-220.
29. Liu L, Wang JG, Celis H, et al.: Implications of the Systolic Hypertension in China Trial. Clin Exp Hypertens 1999, 21:499-505.
30. Wang JG, Staessen JA, Fagard R, et al: Risks of smoking in treated and untreated older Chinese patients with isolated systolic hypertension. J Hypertens 2001, 19:187-192.
31. Staessen JA, Birkenhäger WH, Fagard RH: Dihydropyridine calcium-channel blockers for the treatment of hypertensive patients. Eur Heart J 2000, 21:2-7.
32. Birkenhäger W.H., Forette F, Seux M.L., et al.: Blood pressure, cognitive function and prevention of dementias in older hypertensives. Arch Intern Med 2001, 161:152-156.
33. Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of angiotensin converting enzyme inhibitors, calcium antagonists and other blood pressure lowering drugs on mortality and major cardiovascular morbidity. First cycle of analyses from a program of prospectively designed collaborative overviews of major randomised trials. Lancet 2000, 355:1955-1964.
34. Wang JG, Staessen JA: Antihypertensive drug therapy in older patients. Curr Opin Nephrol Hypertens 2001, 10: 263-269.
35. Duchier J, Iannascoli F, Safar M: Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol 1987, 60:99-102.